Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GVHD”

1,735 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,735 results

Not applicableStudy completedNCT03575767
What this trial is testing

Characteristics and Dynamics of TCR Repertoire in Patients With Hematological Malignancies After Allo-HSCT

Who this might be right for
Hematologic NeoplasmsHematopoietic Stem Cell TransplantationGraft Vs Host Disease+1 more
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableNot Yet RecruitingNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274
Testing effectiveness (Phase 2)Study completedNCT01491958
What this trial is testing

Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndrome
Ohio State University Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT02953678
What this trial is testing

Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 71
Testing effectiveness (Phase 2)Active Not RecruitingNCT06001385
What this trial is testing

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAcute Leukemia+8 more
Center for International Blood and Marrow Transplant Research 313
Early research (Phase 1)UnknownNCT03214289
What this trial is testing

Fecal Microbiota Transplantation for Steroid Resistant and Steroid Dependent Gut Acute Graft Versus Host Disease

Who this might be right for
Stem Cell Transplant ComplicationsGraft Versus Host Disease, AcuteFecal Microbiota Transplantation
Sheba Medical Center 4
Large-scale testing (Phase 3)Study completedNCT01656668
What this trial is testing

Study of the Safety and Effectiveness of BC1036 Capsules to Treat Frequent Long-Term Cough

Who this might be right for
Cough
Respicopea Limited 288
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Not applicableStudy completedNCT00179075
What this trial is testing

Repository: Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic Stem Cell TransplantationGraft vs Host Disease
Vanderbilt University 100
Very early researchStudy completedNCT02181478
What this trial is testing

Intra-Osseous Co-Transplant of UCB and hMSC

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndromes+9 more
Case Comprehensive Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT04960644
What this trial is testing

MTX and Steroid as First-line Therapy for aGVHD

Who this might be right for
Acute GVH Disease
Peking University People's Hospital 157
Not applicableStudy completedNCT01379963
What this trial is testing

A Retrospective Observational Study of Hemoglobin Levels in Patients With Renal Anemia Treated With Mircera (Methoxy Polyethylene Glycol-Epoetin Beta)

Who this might be right for
Anemia, Kidney Disease, Chronic
Hoffmann-La Roche 780
Early research (Phase 1)Study completedNCT03755414
What this trial is testing

Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaMyelodysplastic Syndromes+2 more
Washington University School of Medicine 55
Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26
Not applicableStudy completedNCT00478985
What this trial is testing

Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia

Who this might be right for
Myeloid Leukemia, Chronic
University Hospital, Bordeaux 100
Not applicableUnknownNCT00774449
What this trial is testing

Characterization of Bronchiolitis-obliterans Syndrome (BOS) Following Lung Transplantation

Who this might be right for
Lung TransplantationBronchiolitis Obliterans Syndrome
Hannover Medical School 261
Not applicableLooking for participantsNCT00106925
What this trial is testing

Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants

Who this might be right for
Graft-versus-leukemiaGraft vs Host DiseaseGraft Rejection
National Heart, Lung, and Blood Institute (NHLBI) 1,000
Testing effectiveness (Phase 2)WithdrawnNCT05567406
What this trial is testing

Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic Therapy

Who this might be right for
Chronic Graft Versus Host Disease
Kadmon, a Sanofi Company
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06411184
What this trial is testing

Safety and Efficacy of Treg Cell in the Treatment of GVHD

Who this might be right for
GVHD
Xuzhou Medical University 20
Early research (Phase 1)Looking for participantsNCT04886726
What this trial is testing

PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis

Who this might be right for
Graft Versus Host Disease
Henry Ford Health System 18
Load More Results